5 results

Allergan: together with Abbvie, it  employs more than 2,300 people in Ireland.

Abbvie’s $63 billion approach for Allergan is just the latest episode in what can be a generally bewildering cycle of making and remaking of businesse(...)

Take-up of biosimilars in the Irish health system has been held back by the lack of Government encouragement and inertia among medical practitioners. Photograph: Benis Arapovic/Getty

Efforts to pull together a national policy on biosimilars remain stymied somewhere in the Department of Health but at least some moves are finally bei(...)

Humira is the biggest single item on its medicines bill and finally came off patent this week.

Medicines and their prices are a particular bone of contention. The Government says it cannot afford the inexorable rise in cost: the industry says it(...)

AbbVie’s net revenue for the second quarter rose 17.8 per cent to $6.45 billion. Photograph: Brendan McDermid/Reuters

Drugmaker AbbVie posted higher-than-expected quarterly profit and revenue, driven by demand for flagship drug Humira, and raised its earnings forecast(...)

Sales of AbbVie’s biggest product, the rheumatoid arthritis injection Humira, narrowly missed analysts’ estimates in the fourth quarter, sending the (...)